Avinger, Inc. (AVGR)
USD 0.47
(-20.74%)
USD 0.47
(-20.74%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 10.12 Million USD | 476.31% |
| 2022 | 1.75 Million USD | 143.56% |
| 2021 | -4.03 Million USD | 21.45% |
| 2020 | -5.13 Million USD | -278.13% |
| 2019 | 2.88 Million USD | 132.28% |
| 2018 | -8.92 Million USD | -122.68% |
| 2017 | 39.35 Million USD | 657.85% |
| 2016 | 5.19 Million USD | 138.48% |
| 2015 | -13.49 Million USD | -180.62% |
| 2014 | 16.73 Million USD | -22.38% |
| 2013 | 21.56 Million USD | 204.58% |
| 2012 | -20.61 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -3.05 Million USD | -131.89% |
| 2024 Q1 | 9.56 Million USD | -5.45% |
| 2023 Q2 | 9.73 Million USD | 56.24% |
| 2023 FY | 10.12 Million USD | 476.31% |
| 2023 Q1 | 6.23 Million USD | 254.78% |
| 2023 Q4 | 10.12 Million USD | 56.83% |
| 2023 Q3 | 6.45 Million USD | -33.71% |
| 2022 Q4 | 1.75 Million USD | 243.35% |
| 2022 Q3 | -1.22 Million USD | -685.26% |
| 2022 FY | 1.75 Million USD | 143.56% |
| 2022 Q1 | -4.33 Million USD | -7.64% |
| 2022 Q2 | -156 Thousand USD | 96.4% |
| 2021 Q2 | -11.63 Million USD | 11.93% |
| 2021 Q3 | -7.81 Million USD | 32.82% |
| 2021 Q4 | -4.03 Million USD | 48.43% |
| 2021 FY | -4.03 Million USD | 21.45% |
| 2021 Q1 | -13.21 Million USD | -157.44% |
| 2020 Q1 | 4.16 Million USD | 44.64% |
| 2020 Q4 | -5.13 Million USD | 39.72% |
| 2020 Q3 | -8.51 Million USD | -31629.63% |
| 2020 FY | -5.13 Million USD | -278.13% |
| 2020 Q2 | 27 Thousand USD | -99.35% |
| 2019 Q1 | -7.55 Million USD | 15.32% |
| 2019 Q2 | -957 Thousand USD | 87.34% |
| 2019 Q4 | 2.88 Million USD | 516.93% |
| 2019 Q3 | -691 Thousand USD | 27.8% |
| 2019 FY | 2.88 Million USD | 132.28% |
| 2018 Q1 | -6.89 Million USD | -117.53% |
| 2018 FY | -8.92 Million USD | -122.68% |
| 2018 Q4 | -8.92 Million USD | -379.27% |
| 2018 Q3 | -1.86 Million USD | 19.78% |
| 2018 Q2 | -2.32 Million USD | 66.35% |
| 2017 Q3 | 33.11 Million USD | 16.11% |
| 2017 FY | 39.35 Million USD | 657.85% |
| 2017 Q4 | 39.35 Million USD | 18.83% |
| 2017 Q2 | 28.52 Million USD | 51.33% |
| 2017 Q1 | 18.84 Million USD | 262.95% |
| 2016 Q1 | 3.09 Million USD | 122.93% |
| 2016 Q3 | -2.56 Million USD | -114.51% |
| 2016 Q2 | 17.7 Million USD | 472.14% |
| 2016 Q4 | 5.19 Million USD | 302.22% |
| 2016 FY | 5.19 Million USD | 138.48% |
| 2015 FY | -13.49 Million USD | -180.62% |
| 2015 Q1 | -39.84 Million USD | -338.08% |
| 2015 Q2 | -30.7 Million USD | 22.95% |
| 2015 Q4 | -13.49 Million USD | 47.34% |
| 2015 Q3 | -25.62 Million USD | 16.53% |
| 2014 Q2 | 33.89 Million USD | 177.34% |
| 2014 FY | 16.73 Million USD | -22.38% |
| 2014 Q4 | 16.73 Million USD | -18.46% |
| 2014 Q1 | 12.22 Million USD | -43.32% |
| 2014 Q3 | 20.52 Million USD | -39.44% |
| 2013 FY | 21.56 Million USD | 204.58% |
| 2013 Q1 | 20.61 Million USD | 0.0% |
| 2013 Q4 | 21.56 Million USD | 0.0% |
| 2012 FY | -20.61 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 2.58 Million USD | -292.096% |
| AngioDynamics, Inc. | -70.14 Million USD | 114.428% |
| AtriCure, Inc. | -9.81 Million USD | 203.097% |
| Azenta, Inc. | -618.47 Million USD | 101.636% |
| BioLife Solutions, Inc. | 7.25 Million USD | -39.528% |
| The Cooper Companies, Inc. | 2.44 Billion USD | 99.587% |
| Daxor Corporation | 755.65 Thousand USD | -1239.228% |
| Ekso Bionics Holdings, Inc. | -1.47 Million USD | 788.435% |
| Femasys Inc. | -15.01 Million USD | 167.398% |
| GlucoTrack, Inc. | -4.29 Million USD | 335.568% |
| Harvard Bioscience, Inc. | 38.49 Million USD | 73.707% |
| Hologic, Inc. | 374.4 Million USD | 97.297% |
| ICU Medical, Inc. | 1.45 Billion USD | 99.302% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 100.38% |
| KORU Medical Systems, Inc. | -7.03 Million USD | 243.809% |
| LeMaitre Vascular, Inc. | -5.17 Million USD | 295.593% |
| Innovative Eyewear, Inc. | -4.28 Million USD | 336.038% |
| Innovative Eyewear, Inc. | -4.28 Million USD | 336.038% |
| Masimo Corporation | 804 Million USD | 98.741% |
| Microbot Medical Inc. | -2.28 Million USD | 542.695% |
| Meihua International Medical Technologies Co., Ltd. | -9.59 Million USD | 205.463% |
| Merit Medical Systems, Inc. | 302.22 Million USD | 96.651% |
| Nephros, Inc. | -2.47 Million USD | 509.551% |
| NovoCure Limited | 355.42 Million USD | 97.153% |
| NEXGEL, Inc. | 98 Thousand USD | -10226.531% |
| NEXGEL, Inc. | 98 Thousand USD | -10226.531% |
| Singular Genomics Systems, Inc. | 59.05 Million USD | 82.863% |
| OraSure Technologies, Inc. | -276.9 Million USD | 103.655% |
| Pro-Dex, Inc. | 10.91 Million USD | 7.292% |
| Pulse Biosciences, Inc. | -35.22 Million USD | 128.733% |
| Predictive Oncology Inc. | -5.87 Million USD | 272.348% |
| Precision Optics Corporation, Inc. | 3.02 Million USD | -234.083% |
| QuidelOrtho Corporation | 2.49 Billion USD | 99.594% |
| Repligen Corporation | -39.51 Million USD | 125.608% |
| Sanara MedTech Inc. | 6.64 Million USD | -52.297% |
| STAAR Surgical Company | -147.2 Million USD | 106.875% |
| Sharps Technology, Inc. | -3.01 Million USD | 435.888% |
| Utah Medical Products, Inc. | -92.52 Million USD | 110.937% |
| DENTSPLY SIRONA Inc. | 1.96 Billion USD | 99.485% |
| Jin Medical International Ltd. | -2.81 Million USD | 459.31% |